SCHEMBL8710075

SCHEMBL8710075

Cn1nnc2ccc(CNNc3ccc(Cl)cc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.44
RAB9A P51151 6/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
SLC6A4 P31645 1/20 0.43
CYP19A1 P11511 3/20 0.42
CYP11B1 P15538 1/20 0.42
GFER P55789 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
KEAP1 Q14145 3/20 0.39
RXFP1 Q9HBX9 1/20 0.39
NOTUM Q6P988 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GRM4 Q14833 1/20 0.37
SLC9A1 P19634 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8710124 0.99 NPC1 (0.44) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL8882992 0.76 SLC6A4 (0.33) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL8714943 0.76 SLC6A4 (0.33) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL8712819 0.74 NPC1 (0.42) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL14476937 0.74 KEAP1 (0.53) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL8715787 0.73 NPC1 (0.38) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL8445272 0.73 SLC9A1 (0.48) KDM4ESLC6A4CYP19A1CYP11B1TDP1
SCHEMBL29490311 0.73 SLC9A1 (0.48) KDM4ESLC6A4CYP19A1CYP11B1TDP1
SCHEMBL8710073 0.72 SLC6A4 (0.43) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL19806035 0.71 SLC9A1 (0.41) NPC1RAB9AKDM4ESLC6A4CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5746840-A Process for preparing enantiomerically pure 6-{4-chlorophenyl) (1 H-1,2,4-triazol-1-YL) methyl}-1-methyl-1 H-benzotriazole JANSSEN PHARMACEUTICA, N.V. (BE) 1998-05-05 US disclosed
US-5663354-A Process for preparing enantiomerically pure 6-[(4-chlorophenyl) (1H-1,2,4-triazol-1-yl) methyl]-1-methyl-1H-benzotrizole JANSSEN PHARMACEUTICA, N.V. (BE) 1997-09-02 US disclosed
EP-0668861-A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE 6- (4-CHLOROPHENYL)(1H --TRIAZOL-1,2,4-TRIAZOL-1-YL)METHYL]-1-METHYL-1H --BENZOTRIAZOLE JANSSEN PHARMACEUTICA N.V. (BE) 1995-08-30 EP disclosed
WO-1994011364-A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE 6-[(4-CHLOROPHENYL)(1H^_-TRIAZOL-1,2,4-TRIAZOL-1-YL)METHYL]-1-METHYL-1H^_-BENZOTRIAZOLE JANSSEN PHARMACEUTICA N.V. (BE) 1994-05-26 WO disclosed